OncoHost Email Format
Hospitals and Health CareHaifa, Israel11-50 Employees
OncoHost is a technology company in the hospitals and health care sector, based in Binyamina in the Haifa region of Israel. Its PROphet platform analyzes plasma proteomic patterns and, in non-small cell lung cancer, uses a single blood sample to guide first-line immunotherapy decisions. The NSCLC test provides clinicians with guidance on the initial treatment plan for each patient, supported by a large-scale prospective trial conducted at more than 40 sites with about 1,700 patients. The company serves oncologists and health care providers involved in precision diagnostics and biomarker development, focusing on improving patient outcomes in NSCLC. In 2026, OncoHost participated in AACR 2026 to present new research on proteomic aging biomarkers, illustrating ongoing activity in the field.